Writer's new AI harness study cuts enterprise token spend by 38% and cost per task by 41% across six foundation models, ...

NVIDIA GB300 Grace Blackwell Ultra Superchips are now mass-produced in the U.S. for the first time at Wistron's $700M Fort ...

A deep technical guide to how modern AI really works—from neural networks and transformers to RAG, embeddings, reasoning ...

Explore 100 Mandela Effects so strong you'll question your memory. From movie quotes to logos, discover collective false ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

For the second time in a week, a long-standing conjecture has been disproved by artificial intelligence, highlighting the ...

Security leaders debated what these systems could mean for vulnerability discovery, exploit development and the pace of ...

AI can accelerate implementation, but it cannot take responsibility for architectural quality, security or long-term ...

UCaaS and CCaaS platforms release hundreds of new features every year. User adoption hasn't kept pace and the capability vs.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Follow this tag to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings by Chad de Guzman by Chad de Guzman by Callum Sutherland by Chad de Guzman by ...